Emergent BioSolutions



金融业
股票价格
USD
资产
USD 1.82B
现金及等价物
USD 111.7M
销售成本
USD 381.2M
流动资产
USD 679.5M
流动负债
USD 651.3M
债务
USD 903.2M
股息收益率
0
EBIT
USD -148.1M
EBITDA
USD -113.5M
员工
1.6K
EPS每股收益
USD -0.77
股本和储备
USD 649.3M
销售毛利
USD 10M
债务利息支出
USD 17.9M
贷款资金
USD 446.5M
市值
USD 120.6M
净收入
USD -261.3M
营业费用
USD 555.9M
营业利润
USD -218M
普通股股本
USD 100K
PE价格收益
14.4
税前利润
USD -130.8M
销售收入
USD 276.6M
销售和管理费用
USD 182.8M
股票
USD 328.9M
贸易债权人
USD 112.2M
应收帐款人
USD 290.1M


Ebit 更改 日
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Akebia Therapeutics USD 13.51M 27.82M 2025-03
ALKERMES USD 89.08M 3.9M 2025-09
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amarin USD -1.7M 8.47M 2025-09
ANI Pharmaceuticals USD 22.83M 7.66M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Coherus Biosciences USD -45.43M 3.19M 2025-03
Exact Sciences USD -25M 22.85M 2025-09
Exelixis USD 235.91M 20.45M 2025-12
Glaxosmithkline GBP 3.76B 1.69B 2025-09
Heron Therapeutics USD -4.46M 5.76M 2024-09
Ionis Pharmaceuticals USD -160.18M 304.96M 2025-09
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Lexicon Pharmaceuticals USD -49.63M 5.39M 2023-09
Lonza CHF 673M 54M 2025-06
Merck USD 6.24B 1.32B 2025-12
Moderna USD -857M 597M 2025-12
Myriad Genetics USD -5.5M 11.1M 2025-03
Nektar Therapeutics USD -34.34M 3.68M 2024-09
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Pacira USD 13.15M 2.92M 2025-09
Pfizer USD 4.65B 71M 2025-12
PTC Therapeutics USD 3.49M 38.35M 2025-09
Sanofi EUR 1.7B 2.17B 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
United Therapeutics USD 389.3M 112.4M 2025-09
Vanda Pharmaceuticals USD -10.28M 721K 2024-12
Xoma USD -10.08M 4.4M 2024-06


Emergent BioSolutions - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.